Skip to main content

Table 3 Standardised difference of confounding variables between TPV/PR and BOC/PR patients prior to matching

From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

 

Mean TPV/PR

Mean BOC/PR

Standardised difference

Treatment experinced

0.31

0.24

0.154

Presence of cirrhosis

0.29

0.26

0.058

Age

45.73

47.62

−0.174

BMI

26.7

26.73

−0.006

Baseline HCV > 800,000

0.49

0.6

−0.203

GT1

0.19

0.11

0.225

GT1b

0.26

0.33

−0.153

IL28B CT

0.49

0.53

−0.072

IL28B TT

0.17

0.11

0.119

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us